NIVF vs SRXH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 20, 2026

NIVF

34.6
AI Score
VS
SRXH Wins

SRXH

56.1
AI Score

Investment Advisor Scores

NIVF

35score
Recommendation
SELL

SRXH

56score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NIVF SRXH Winner
Forward P/E 0.0092 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 11.9% -9.4% NIVF
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 34.6/100 56.1/100 SRXH
Profit Margin 209.0% 0.0% NIVF
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD SRXH

Relative Price Performance (Last 90 Days)

NIVF 1M: +36.0% · 3M: +12.7% SRXH 1M: -4.7% · 3M: +1268.5%

Current Technical Phase

NIVF

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.1 · Price: $0.76

SRXH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 56

RSI (14): 56.1 · Price: $1.72

Fundamentals Snapshot

Metric NIVF SRXH
Market Cap
Forward P/E 0.0 0.0
Trailing P/E 0.0 0.0
Revenue (TTM)
Revenue Growth 0.1% -0.1%
Gross Margin 0.2% 0.3%
Operating Margin -3.5% -0.9%
EPS 328.32 68.20
Dividend Yield 0.00%

Frequently Asked Questions

Based on our detailed analysis, SRXH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.